Newsroom ARCHIVE
Welcome to the newsroom archive
of AOP Health
Please find below archived press releases
Press Releases
Explore the archived press releases about AOP Health, its products, studies and cooperations. We will be happy to answer any questions or comments you may have via aop-health@aoporphan.com
AOP Orphan announces EU Marketing Authorization for BESREMi® (Ropeginterferon alfa-2b) for rare blood cancer (PV)
21. 2. 2019
AOP Orphan announces positive CHMP opinion for Ropeginterferon alfa-2b/BESREMi®
17. 12. 2018
AOP Orphan announces three-year results on Ropeginterferon alfa-2b in Polycythemia Vera at the American Society of Hematology (ASH) Annual Meeting 2018
3. 12. 2018
AOP Orphan is the winner of the innovation award MERCUR’18 in the category ”Life Science”
15. 11. 2018
Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo
12. 10. 2018
AOP Orphan announces progress of its European Marketing Authorization Procedure of Ropeginterferon alfa-2b
11. 6. 2018